| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/27/1993 | EP0524582A1 Diclofenac sodium plaster |
| 01/27/1993 | EP0524579A1 Improved oral dosing formulations of dideoxy purine nucleosides |
| 01/27/1993 | EP0524308A1 Nutritional supplement containing vitamin e |
| 01/27/1993 | EP0409940A4 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids |
| 01/27/1993 | CN1068268A Non-stinging vaccine composition |
| 01/27/1993 | CN1068265A Female hormone plaster |
| 01/26/1993 | WO1993001803A1 Controlled release verapamil tablet |
| 01/26/1993 | US5182407 Solubilizing and/or dispersant compounds, preparation process and compositions containing them |
| 01/26/1993 | US5182368 Lymphokines, antibodies |
| 01/26/1993 | US5182274 Nonionic surfactant, citric acid or tartaric acid chelating agent |
| 01/26/1993 | US5182270 Stabilizing preparation for thymoxamine |
| 01/26/1993 | US5182112 Antidiarrheal compositions containing laperamide hydrochloride and a saccharide |
| 01/26/1993 | US5182107 Delivering nerve growth factor across blood brain barrier to brain |
| 01/26/1993 | US5182096 Compound applicable as carrier for substances or active chemical, physical or biological products |
| 01/26/1993 | US5182081 Product to be used in occlusive epicutaneous testing for the purpose of demonstrating contact allergy to formaldehyde |
| 01/26/1993 | CA1313140C Pharmaceutical composition containing cimetidine |
| 01/26/1993 | CA1313135C Cholestyramine composition and process for its preparation |
| 01/26/1993 | CA1313133C Therapeutic agents |
| 01/26/1993 | CA1313132C Coating membrane and compositions prepared therefrom |
| 01/26/1993 | CA1313131C Forms for application of -interferons |
| 01/25/1993 | CA2074315A1 Process for the manufacture of bioerodible poly(ortho ester)s and polyacetals |
| 01/25/1993 | CA2070751A1 Proteins |
| 01/23/1993 | WO1993001837A1 Conjugated moieties for chelating paramagnetic metals |
| 01/21/1993 | WO1993000930A1 Improvements in or relating to contrast agents |
| 01/21/1993 | WO1993000929A1 Novel compositions based on taxane class derivatives |
| 01/21/1993 | WO1993000928A1 Novel compositions based on taxane class derivatives |
| 01/21/1993 | WO1993000917A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 01/21/1993 | WO1993000915A1 Colestipol hydrochloride high-content tablets |
| 01/21/1993 | WO1993000905A1 Tropical composition containing penciclovir |
| 01/21/1993 | WO1993000898A1 Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof |
| 01/21/1993 | WO1993000891A1 Enzyme-sensitive enteric preparation for oral administration |
| 01/21/1993 | WO1993000890A1 Collagen composites for controlled drug release |
| 01/21/1993 | WO1993000888A1 Loading technique for preparing drug containing liposomes |
| 01/21/1993 | WO1993000873A1 Composition and method for transdermal delivery of diclofenac |
| 01/21/1993 | WO1992020316A3 Targeted delivery of genes encoding immunogenic proteins |
| 01/21/1993 | DE4222647A1 Peptid-zubereitungen Peptide preparations |
| 01/21/1993 | CA2112751A1 Composition and method for transdermal delivery of diclofenac |
| 01/21/1993 | CA2112473A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 01/21/1993 | CA2112109A1 Improvements in or relating to contrast agents |
| 01/21/1993 | CA2111593A1 Loading technique for preparing drug containing liposomes |
| 01/20/1993 | EP0523776A2 Oral compositions containing a phosphopeptide |
| 01/20/1993 | EP0523537A1 Transdermal therapeutic system for the administration of drugs having bronchodilating activity |
| 01/20/1993 | EP0523391A1 Use of HPV-16 E6 and E7-gene derived peptides for the diagnostic purpose |
| 01/20/1993 | EP0523376A1 Preserved pharmaceutical preparations |
| 01/20/1993 | EP0523315A1 Gas mixture for anesthesia consisting of xenon, oxygen and helium |
| 01/20/1993 | EP0523294A1 Paraffin hydrocarbon dispersion of titanium dioxide fine-particles |
| 01/20/1993 | EP0523189A1 Cationic lipids for intracellular delivery of biologically active molecules |
| 01/20/1993 | EP0523184A1 Film-forming proteinaceous emulsion |
| 01/20/1993 | EP0523150A1 Device and method for enhanced administration of physostigmine |
| 01/20/1993 | EP0523127A1 Skin-compatible aqueous tenside mixtures |
| 01/20/1993 | EP0523086A1 Pharmaceutical aqueous solution of 4- 2-(benzolsulphonylamino)-ethyl]-phenoxyacetic acid |
| 01/20/1993 | EP0523037A1 Fluid resuscitation |
| 01/20/1993 | EP0343239B1 Glassy matrix for administration of beneficial agent |
| 01/20/1993 | EP0257086B1 Skinpenetration enhancing compositions |
| 01/20/1993 | EP0126751B2 Method of preparing controlled-release preparations for biologically active materials |
| 01/19/1993 | US5180747 Stabilized fat-soluble vitamin compositions |
| 01/19/1993 | US5180716 Improved bioactivity, side effect reduction |
| 01/19/1993 | US5180590 Mixture with sodium salt, sodium bicarbonate and citric acid |
| 01/19/1993 | US5180584 Surfactant mixture for shampoo and detergents for washing hair or skin |
| 01/19/1993 | US5180583 Method for the treatment of bleeding disorders |
| 01/19/1993 | CA1312835C Molecules with antibody combining sites that exhibit catalytic properties |
| 01/19/1993 | CA1312824C Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids |
| 01/18/1993 | CA2073788A1 Oral compositions containing a phosphopeptide |
| 01/17/1993 | WO1993001836A1 Method of producing semi-solid preparations containing micro-particulate substances |
| 01/17/1993 | CA2091684A1 Method of producing semi-solid preparations containing micro-particulate substances |
| 01/14/1993 | DE4122337A1 Stable 5-amino-salicylic acid enema suspensions |
| 01/14/1993 | DE4122210A1 Conjugate comprising antitumoural cpd. and protein in native form - which is stable and accumulates at high levels in the tumour |
| 01/13/1993 | EP0522937A1 Taxane derivatives containing compositions |
| 01/13/1993 | EP0522936A1 Taxane derivatives containing compositions |
| 01/13/1993 | EP0522491A1 Compositions based on hyaluronic acid |
| 01/13/1993 | EP0522433A1 Oral aqueous solutions containing ubidecarenone |
| 01/13/1993 | EP0522226A1 Eyedrop solution for the treatment of ocular hypertension containing ketauserin |
| 01/13/1993 | EP0522141A1 Method for masking the taste of a medicament |
| 01/13/1993 | EP0522122A1 Pharmaceutical compositions containing amethocaine |
| 01/13/1993 | EP0522006A1 Compositions comprising cytotoxic agent and permeation enhancers |
| 01/13/1993 | EP0521988A1 Device and method for iontophoretic drug delivery. |
| 01/13/1993 | EP0521880A1 Contrast media. |
| 01/13/1993 | CN1067811A Transdermal nicotine absorption dosage unit and process |
| 01/13/1993 | CN1067809A Oral presentation forms for acid-unstable active compounds |
| 01/12/1993 | US5179189 Fatty acid terminated polyanhydrides |
| 01/12/1993 | US5179122 Nutritional supplement containing vitamin e |
| 01/12/1993 | US5179086 Containing cholesterol for treatment of psoriasis |
| 01/12/1993 | US5179079 Nasal formulation and intranasal administration therewith |
| 01/12/1993 | US5178883 Method for promoting hair growth |
| 01/12/1993 | US5178882 Viral decoy vaccine |
| 01/12/1993 | US5178881 Anhydrous topical compositions which dry rapidly on contact |
| 01/12/1993 | US5178879 Capsaicin gel |
| 01/12/1993 | US5178875 Phosphatides with tert-butanol, clarification of water, mixing with solvent then removal |
| 01/12/1993 | US5178860 Adjuvant complexes and vaccine made therefrom |
| 01/12/1993 | US5178853 Consisting of a bottle of glass or polyethleneterephthalate with a dropper of polypropylene or polyethylene coated bromobutyl rubber |
| 01/12/1993 | US5178143 Electrically conductive gel composition |
| 01/12/1993 | CA1312547C Fatty acids and their small chain esters as penetration enhancers in aqueous systems |
| 01/07/1993 | WO1993000443A1 Purification of recombinant apolipoprotein e from bacteria |
| 01/07/1993 | WO1993000434A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 01/07/1993 | WO1993000432A1 Bmp-9 compositions |
| 01/07/1993 | WO1993000407A1 Dye-treated materials |
| 01/07/1993 | WO1993000388A1 Method of preparing nanoparticles |
| 01/07/1993 | WO1993000383A1 Pulsed release of high molecular weight therapeutic agents from bioerodible polymer compositions |
| 01/07/1993 | WO1993000367A1 Abrin variants and immunnotoxins |
| 01/07/1993 | WO1993000352A1 Sequence-specific binding polymers for duplex nucleic acids |